Clinical Trial Update: PEA in Functional Dyspepsia [NA]

View source ↗

Summary

A clinical trial investigating palmitoylethanolamide (PEA) for functional dyspepsia is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Functional Dyspepsia

Drugs mentioned

• PEA (palmitoylethanolamide)

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Dyspepsia and Other Specified Disorders of Function of Stomach | NA | Status: RECRUITING